🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Tirzepatide and cholesterol — March 2026 Page 7

Tirzepatide and cholesterol — March 2026

paige_pharma Tue, Dec 16, 2025 at 4:18 AM 37 replies 1,549 viewsPage 7 of 8
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Dec 24, 2025 at 2:41 AM#31

The figures, for anyone assembling their own picture. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

25 0sarah_nash92, FitDadDave, RunnerRach and 22 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Dec 24, 2025 at 4:40 PM#32

Following on from EndoResFellow — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Dec 24, 2025 at 8:40 PM
24 24SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 21 others
Reply Quote Save Share Report
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Dec 25, 2025 at 6:40 AM#33
bri_stats said:
Say what you would expect to see if you were wrong, before you look.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

23 23kevin_tulsa, Dr.PainCLE, mike_mealprep and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
alex_tucson
Member
567
2,345
May 2024
Tucson, AZ
Dec 25, 2025 at 8:40 PM#34
bri_stats said:
Say what you would expect to see if you were wrong, before you look.

True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.

Worth separating that from tirzepatide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Dec 25, 2025 at 10:40 PM
22 22ricardo_MIA, BrianDallas92, labquiet_amy and 19 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Dec 26, 2025 at 10:40 AM#35
bri_stats said:
Say what you would expect to see if you were wrong, before you look.

That reframing is the part I needed. Sending this to two other people who asked me the same thing last week.

21 21RickReta_CO, PharmHunterJen, TomTeleRx and 18 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register